0 items USD 0.00Search
- Did you mean
- crohn disease
Your search for "Crohn’s disease" gave back 31600 results.
The global Remicade (Infliximab) Monoclonal Antibody market size is expected to reach $ 3781.3 million by 2029, rising at a market growth of 5.4%...
Catalog:
GIR
June 2023
Price: USD 4,480.00
Humira (adalimumab) is a tumor necrosis factor (TNF) blocker that reduces the effects of a substance in the body that can cause inflammation. Humira...
Catalog:
MRRPB5
February 2024
Price: USD 2,900.00
The global Humira market size was valued at US$ 16700 million in 2023. With growing demand in downstream market, the Humira is forecast to a...
Catalog:
LPI
January 2024
Price: USD 3,660.00
Humira (adalimumab) is a tumor necrosis factor (TNF) blocker that reduces the effects of a substance in the body that can cause inflammation. Humira...
Catalog:
GIR
April 2023
Price: USD 3,480.00
Smart pill technology is a revolutionary technological innovation that has reduced the gap between healthcare and digital technology. Smart pills or...
Catalog:
MRRPB5
November 2023
Price: USD 3,350.00
The global Humira market size was valued at USD 17560 million in 2023 and is forecast to a readjusted size of USD 9840.6 million by 2030 with a CAGR...
Catalog:
GIR
January 2024
Price: USD 3,480.00
The global Remicade (Infliximab) Monoclonal Antibody market size was valued at USD 2623.8 million in 2022 and is forecast to a readjusted size of USD...
Catalog:
GIR
June 2023
Price: USD 3,480.00
Tysabri (natalizumab) is a monoclonal antibody used in to treat relapsing forms of multiple sclerosis. Tysabri is also used to treat moderate to...
Catalog:
MRRPB5
September 2023
Price: USD 2,900.00
Inflammatory bowel disease is a group of medical conditions that causes chronic inflammation in the digestive tract. The inflammatory bowel disease...
Catalog:
MRRPB5
February 2024
Price: USD 2,900.00
Tysabri (natalizumab) is a monoclonal antibody used in to treat relapsing forms of multiple sclerosis. Tysabri is also used to treat moderate to...
Catalog:
MRRPB5
September 2023
Price: USD 2,900.00
Tysabri (natalizumab) is a monoclonal antibody used in to treat relapsing forms of multiple sclerosis. Tysabri is also used to treat moderate to...
Catalog:
MRRPB5
September 2023
Price: USD 2,900.00
Infliximab (trade names Remicade among others) is a chimeric monoclonal antibody biologic drug that works against tumor necrosis factor alpha (TNF-α...
Catalog:
MRRPB5
October 2023
Price: USD 2,900.00
Cimzia (certolizumab) Drug is a biologic medication that belongs to the class of drugs known as TNF-alpha inhibitors. It is used to treat a variety...
Catalog:
HJResearch
June 2023
Price: USD 3,200.00
Entyvio (vedolizumab) is a prescription drug used to treat inflammatory bowel diseases such as ulcerative colitis and Crohn's disease. The drug...
Catalog:
HJResearch
June 2023
Price: USD 3,200.00
Tysabri (natalizumab) is a monoclonal antibody used in to treat relapsing forms of multiple sclerosis. Tysabri is also used to treat moderate to...
Catalog:
MRRPB5
September 2023
Price: USD 2,900.00
